AMNEAL PHARMACEUTICALS INC (AMRX) Stock Analyst Ratings
NASDAQ:AMRX - Nasdaq - US03168L1052 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 80% to AMRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 11.22. This target is 40.43% above the current price.
AMRX was analyzed by 10 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about AMRX.
In the previous month the buy percentage consensus was at a similar level.
AMRX was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-10-02 | Truist Securities | Maintains | Buy -> Buy |
| 2024-09-06 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2024-08-13 | Barclays | Maintains | Overweight -> Overweight |
| 2024-08-12 | Truist Securities | Maintains | Buy -> Buy |
| 2024-05-06 | Truist Securities | Reiterate | Buy -> Buy |
| 2024-05-06 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-03-21 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-03-04 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-01-29 | Barclays | Maintains | Overweight -> Overweight |
| 2023-11-08 | Truist Securities | Maintains | Buy -> Buy |
| 2023-09-06 | Truist Securities | Reiterate | Buy -> Buy |
| 2023-08-07 | Barclays | Maintains | Overweight -> Overweight |
| 2023-08-07 | Truist Securities | Maintains | Buy -> Buy |
| 2023-08-07 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-05-08 | Piper Sandler | Maintains | Overweight |
| 2023-03-29 | Truist Securities | Maintains | Buy |
| 2023-03-10 | Barclays | Maintains | Overweight |
| 2023-03-03 | BMO Capital | Maintains | Market Perform |
| 2023-03-03 | Goldman Sachs | Maintains | Buy |
| 2022-08-08 | Goldman Sachs | Maintains | Buy |
| 2022-05-12 | Goldman Sachs | Maintains | Buy |
| 2021-03-08 | Goldman Sachs | Upgrade | Sell -> Buy |